Fellowships

Keywords

Please wait while we gather your results.

Fellowship Listings

Postdoctoral Fellow - University of Iowa Children's Hospital

5/12/2022 - A postdoctoral fellow position is available in Dr. Janice Staber’s laboratory in the Stead Family Department of Pediatrics, Division of Hematology/Oncology at the University of Iowa Children’s Hospital. Dr. Staber’s NIH-funded laboratory focuses on the development and application of vector systems for the treatment of inherited disorders and the effects of cerebral microbleeds and neuroinflammation on brain structure and behavior changes in hemophilia A. Postdoctoral scholar will design, perform, and analyze experiments related to bleeding and clotting disorders and outcomes in animal models. Our laboratory aims to apply our knowledge to improve the quality of life, treatment, and outcomes for people with bleeding disorders.

Postdoctoral Fellow and Research Technologist - Versiti Blood Research Institute, Wisconsin

4/28/2022 - We are seeking highly self-motivated candidates for Research Technologist and Postdoctoral Fellow positions in our laboratory of Metabolism, Fibrinolysis and Thrombosis at the Versiti Blood Research Institute (BRI) in Milwaukee, Wisconsin. The overall goal of our research laboratory is to understand the interactions between blood clot lysis and lipid/lipoprotein metabolism in thrombosis, atherosclerosis and bleeding disorders. The ideal candidate will be motivated with career goals and have experience in molecular biology laboratory experiments, and handling and performing procedures upon experimental mouse models.

Postdoctoral Fellow - The Children's Hospital of Philadelphia

4/28/2022 - A postdoctoral fellow position is available in Dr. Rodney M. Camire’s laboratory in the Division of Hematology at The Children's Hospital of Philadelphia, Research Institute. His NIH-funded laboratory using specialized recombinant clotting factors, biochemical and structural methods, imaging techniques, genetically modified mice, in combination with in vitro and in vivo studies to better understand how clotting factors work and how disturbances in their function lead to bleeding and thrombosis. The laboratory is also interested in using this information to develop new protein and gene-based therapeutic approaches to treat hemophilia, other rare bleeding disorders, and thrombosis which are major causes of morbidity and mortality worldwide.